Structural determination of an unknown degradation product in posaconazole drug product using CASI technology in a Fourier transform ion cyclotron resonance mass spectrometer

Rapid Communications in Mass Spectrometry

Volumn 25, Issue 23, 2011, Pages 3650-3655

  Zhong, Wendy ^a   Yang, Jiong ^a   Yang, Xi ^b  

^a MERCK RESEARCH LABORATORIES   (United States)

^b Merck   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEGRADATION; FOURIER TRANSFORMS; SPECTROMETERS;

DEGRADATION PRODUCTS; FOURIER TRANSFORM ION CYCLOTRON RESONANCE MASS SPECTROMETERS; STRUCTURAL DETERMINATION;

DRUG PRODUCTS;

EID: 81555223069     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.5249     Document Type: Letter

References (9)

1. D. S. Schiller, H. B. Fung,. Clin. Therapeutics 2007, 29, 1862.
2. L. Pagano, M. Caira, C. G. Valentini, B. Posteraro, L. Fianchi,. Blood Rev. 2010, 24, 51.
3. G. M. Keating,. Drugs 2005, 65, 1553.
4. H. A. Torres, R. Y. Hachem, R. F. Chemaly, D. P. Kontoyiannis, I. I. Raad,. Lancet Infect. Dis. 2005, 5, 775.
5. W. Feng, H. Liu, G. Chen, R. Malchow, F. Bennett, E. Lin, B. Pramanik, T. M. Chan,. J. Pharmaceut. Biomed. Anal. 2001, 25, 545.
6. N. V. V. S. S. Raman, A. V. S. S. Prasad, K. R. K. Reddy,. J. Pharmaceut. Biomed. Anal. 2011, 55, 662.
7. G. Kruppa, P. D. Schnier, K. Tabei, S. van Orden, M. M. Siegel,. Anal. Chem. 2002, 74, 3877.
8. G. A. Doss, R. R. Miller, Z. Zhang, Y. Teffera, R. P. Nargund, B. Palucki, M. K. Park, Y. S. Tang, Y. S. D. C. Evans, T. A. Baillie, R. A. Stearns,. Chem. Res. Toxicol. 2005, 18, 271.
9. W. Zhong, B. D. Hilton, G. E. Martin, L. Wang, S. Yip,. J. Heterocycl. Chem. 2011, accepted.